Mycophenolsäure Hexal (Mycophenolic Acid)

Mycophenolic Acid, the active ingredient in Mycophenolsäure Hexal, is an immunosuppressant presented as an oral formulation for oral use. It is used to prevent organ transplant rejection and to treat lupus nephritis in appropriate patients.

GNH USA supplies Mycophenolsäure Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mycophenolic Acid acts as an immunosuppressive agent that inhibits lymphocyte proliferation, making it valuable in transplant and autoimmune settings.

- Organ transplant rejection: helps prevent acute and chronic rejection of transplanted organs. - Lupus nephritis: reduces kidney inflammation and preserves renal function in patients with systemic lupus erythematosus.

Mycophenolic Acid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools. - Headache: transient cranial discomfort. - Abdominal pain: cramping or discomfort in the stomach area. - Infections: increased susceptibility to bacterial, viral or fungal infections. - Tremor: fine shaking of hands or limbs.

Serious or Rare Side Effects: - Leukopenia: marked reduction in white blood cells. - Severe infections: opportunistic or life‑threatening infections. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Malignancy: increased risk of certain cancers with long‑term use. - Progressive multifocal leukoencephalopathy (PML): rare demyelinating brain disease.

Before initiating therapy, clinicians should assess baseline laboratory values and patient risk factors.

- Monitor blood counts: perform regular complete blood count tests. - Monitor liver function: check hepatic enzymes periodically. - Avoid in pregnancy: contraindicated due to teratogenic risk. - Use effective contraception: both male and female patients of reproductive potential must use reliable birth control. - Adjust in renal impairment: dose may need modification based on renal function. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Mycophenolic Acid can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Cyclosporine or tacrolimus: increased risk of nephrotoxicity and infections. - Live vaccines: may cause uncontrolled infection.

Moderate Interactions (Monitor Closely): - Warfarin: potential for enhanced anticoagulant effect. - Antacids containing aluminum or magnesium: may reduce absorption of mycophenolic acid.